The immune system works best if the lymphoid cells have a delicately balanc
ed intermediate level of glutathione. Even moderate changes in the intracel
lular glutathione level have profound effects on lymphocyte functions. Cert
ain functions, such as the DNA synthetic response, are exquisitely sensitiv
e to reactive oxygen intermediates and, therefore, are favoured by high lev
els of the antioxidant glutathione. Certain signal pathways, in contrast, a
re enhanced by oxidative conditions and favoured by low intracellular gluta
thione levels. The available evidence suggests that the lymphocytes from he
althy human subjects have, on average, an optimal glutathione level. There
is no indication that immunological functions such as resistance to infecti
on or the response to vaccination may be enhanced in healthy human subjects
by administration of glutathione or its precursor amino acid cysteine. How
ever, immunological functions in diseases that are associated with a cystei
ne and glutathione deficiency may be significantly enhanced and potentially
restored by cysteine supplementation. This factor has been studied most ex
tensively in the case of human immunodeficiency virus (HIV)-infected patien
ts who were found to experience, on average, a massive loss of S equivalent
to a net loss of approximately 4 g cysteine/d. Two randomized placebo-cont
rolled trials have shown that treatment of HIV-infected patients with N-ace
tylcysteine caused in both cases a significant increase in all immunologica
l functions under test, including an almost complete restoration of natural
killer cell activity. It remains to be tested whether cysteine supplementa
tion may be useful also in other diseases and conditions that are associate
d with a low mean plasma cystine level and impaired immunological functions
.